Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

U.S. Food and Drug Administration expands approval of Yervoy® (ipilimumab) to include pediatric pati

worldpharmanewsJuly 25, 2017

Tag: FDA , Bristol-Myers Squibb

PharmaSources Customer Service